Senator Collins Secures Commitment from FDA Nominee to Prevent Drug Shortages, Lower Drug Prices
Read More...
There is no question that our nation’s health care system requires substantial reform. The status quo of soaring health care costs, struggling families, and health care provider shortages across Maine and the nation is unacceptable. Senator Collins frequently works with her colleagues on both sides of the aisle to address these and other important issues facing our nation such as improved mental health care, drug treatment programs, supporting America’s caregivers, and nutrition programs.
As a native to northern Maine, Senator Collins understands the specific challenges that rural communities face for medical care. Throughout her time in the Senate, Senator Collins has consistently supported programs to expand access to and improve the health care system, particularly for citizens living in rural areas.
As a freshman legislator, Senator Collins founded the Senate Diabetes Caucus and has since led the effort to more than triple federal funding for diabetes research.
Senators Collins, Grassley Urge Colleagues to Support Efforts Underway to Lower Cost of Prescription Drugs
Read More...
Senator Collins & MaineHealth’s Chief Pharmacy Officer Shine National Spotlight on Growing Crisis of Drug Shortages
Senate Committee Advances Bill to Support the Health and Wellbeing of Family Caregivers Authored by Collins, Baldwin
Washington, D.C. — This morning, the Senate Health Committee voted to advance legislation introduced by U.S. Senators Susan Collins (R-ME) and Tammy Baldwin (D-WI) to support the health and wellbeing of family caregivers. The Lifespan Respite Care Reauthorization Act of 2019 now heads to the floor for consideration by the full Senate. Senators Collins and Baldwin are members of the Health Committee.
This bipartisan bill would authorize $10 million annually for the Lifespan Respite Care program from fiscal year 2020 through fiscal year 2024.
Legislation Introduced by Senators Collins, Smith to Combat Lyme and Other Tick-Borne Diseases Clears Senate Hurdle
Bill to Help Prevent Drug Shortages Introduced by Senators Collins, Smith
Washington, D.C.—U.S. Senator Susan Collins (R-ME), the Chairman of the Aging Committee, and Senator Tina Smith (D-MN) introduced the Mitigating Emergency Drug Shortages (MEDS) Act, legislation that would help increase the supplies of vital drugs needed to treat or prevent a wide variety of diseases, illnesses, and conditions.
Senator Collins’ Statement on Vote to Reverse Administration’s Changes to 1332 Waiver Policy
Washington, D.C. — U.S. Senator Susan Collins released this statement following her vote in favor of a resolution to reverse the Administration’s policy on 1332 waivers:
“While I support giving states more flexibility to help increase coverage and improve affordability, the Administration’s guidance that allows states to use 1332 waivers to expand Short-Term Limited Duration plans is not the solution. I am concerned that doing so could potentially jeopardize protections for some enrollees who have pre-existing conditions.
Senator Collins Recognized for Leadership in Fighting Alzheimer’s at UsAgainstAlzheimer’s Reception
Senator Collins, Bipartisan Group Call for Expanded Access to Care and Resources for Families with Alzheimer’s
Washington, D.C.—U.S.
Collins, King Join Bipartisan Push to Extend Funding for Community Health Centers
WASHINGTON, D.C. – Today, U.S. Senators Susan Collins (R-Maine) and Angus King (I-Maine) joined a bipartisan group of 25 Senators to urge Senate Leadership to ensure long-term funding for community health centers (CHCs), which provide care to more than 200,000 Mainers. The letter calls for immediate passage of the Community Health Investment, Modernization, and Excellence (CHIME) Act of 2019, which would reauthorize the Community Health Center Fund (CHCF) and the National Health Service Corps for five years.
Senators Collins, King Announce Maine Locations for 2019 Drug Take-Back Day
For the first time, collection sites will accept vaping devices and associated substances.
Washington, D.C. – Ahead of the U.S. Drug Enforcement Agency’s National Prescription Drug Take-Back Day this Saturday, October 26th, U.S. Senators Susan Collins (R-ME) and Angus King (I-ME) announced the locations of the Maine collection sites. Click HERE for the complete list of locations.
Senator Collins, HUD Administrator, Local Officials Announce Nearly $15M to Reduce Lead Hazards in Maine
Biddeford, ME — U.S. Senator Susan Collins, the Chairman of the Housing Appropriations Subcommittee, participated in a press conference at Biddeford City Hall today announcing $14,811,466 to support lead abatement projects by the City of Biddeford, the City of Lewiston, the City of Portland, and the Maine State Housing Authority. This funding, which was awarded through the Department of Housing and Urban Development (HUD), will help protect Maine children and families from lead-based paint and home health hazards.
Collins, Cardin Applaud the Passage of Resolution to Recognize Direct Support Professionals in Health Care
Washington, D.C. — U.S. Senators Susan Collins (R-ME) and Ben Cardin (D-MD) introduced a resolution this week designating September 8 through September 14 as National Direct Support Professionals Recognition Week to recognize the contribution of Direct Support Professionals (DSPs) to the nation’s health care system. Senator Angus King (I-ME) cosponsored the legislation.
ICYMI: Senators Collins, Grassley Pen Op-Ed on Their Work to Lower Drug Prices
Washington, D.C.—U.S. Senator Susan Collins (R-ME), the Chairman of the Aging Committee, and U.S. Senator Chuck Grassley (R-IA), the Chairman of the Senate Finance Committee, authored an op-ed that appeared in the Portland Press Herald today regarding their efforts to make medications more affordable and their support for the Prescription Drug Pricing Reduction Act.
Chairman Collins Convenes Senate Field Hearing at UMaine on Lyme Disease and Other Tick-Borne Diseases
Senator Collins Updates Belfast Rotary Club on Her Efforts to Reduce Prescription Drug Costs, Invest in Biomedical Research
Senator Collins’ Statement on Administration’s Plan to Allow Prescription Drug Importation from Canada
Washington, D.C. — U.S. Senator Susan Collins issued this statement following the announcement by the Administration that it is has released a new proposal to safely import certain lower cost prescription drugs from Canada:
Senator Collins Highlights Bipartisan Work Underway to Lower Cost of Prescription Drugs
Read More...
Patients, Health Care Providers Endorse Bipartisan Bill Introduced by Collins, Shaheen to Roll Back Over a Decade of Insulin Price Hikes
Senators Collins, King Announce More Than $725,000 for Maine Medical Center
Washington, D.C. — U.S. Senators Susan Collins and Angus King announced that Maine Medical Center has been awarded $725,933 to develop new rural residency programs while achieving accreditation through the Accreditation Council for Graduate Medical Education. The funding was awarded through the Health Resources and Services Administration’s (HRSA) Rural Residency Planning and Development Program (RRPD).
Collins, Shaheen Lead Bipartisan Push to Rollback Over a Decade of Insulin Price Hikes
Washington, D.C. — As insulin prices continue to climb and Americans throughout the nation risk their lives by rationing their insulin supplies, U.S. Senators Susan Collins (R-ME) and Jeanne Shaheen (D-NH) announced new legislation to combat these skyrocketing costs and hold health care middlemen accountable.
Importance of Type 1 Diabetes Research and the Special Diabetes Program Focus of Aging Committee Hearing
Read More...
9-Year-Old Mainer Tells Senator Collins’ Committee about Impact of Type 1 Diabetes on Her Life and Importance of Research
Senator Collins: DOJ Should Defend ACA, Protections for Pre-Existing Conditions
WASHINGTON, D.C.— As the U.S. Court of Appeals for the Fifth Circuit hears oral arguments on a case that could determine the future of the Affordable Care Act (ACA), U.S. Senator Susan Collins, a member of the Senate Health Committee, again urged the Department of Justice (DOJ) to defend critical consumer protections for pre-existing conditions and reconsider its position of urging the court to strike down the entire ACA.
Pages
